Side-by-side comparison of AI visibility scores, market position, and capabilities
Geneva luxury holding company (SIX: CFR) at €23B+ revenue; FY2025 +4% with Jewellery Maisons (Cartier/Van Cleef) up high single-digits and €8.3B net cash competing with LVMH for global hard luxury market leadership.
Compagnie Financière Richemont SA is a Geneva, Switzerland-based luxury goods holding company — listed on the SIX Swiss Exchange (SIX: CFR) and Johannesburg Stock Exchange with the Rupert family retaining a 51% controlling voting stake — operating as the world's second-largest luxury group by revenue, with €23+ billion in trailing twelve-month sales and 38,900 employees across 36 locations in 130+ countries. Richemont reports FY2025 (year ended March 31, 2025) full-year sales up 4% at actual and constant exchange rates, led by a high single-digit increase at Jewellery Maisons, with a net cash position of €8.3 billion reflecting consistent profitability. The group's three divisions are Jewellery Maisons (Cartier, Van Cleef & Arpels, Buccellati — 67% of sales), Specialist Watchmakers (IWC Schaffhausen, Jaeger-LeCoultre, Vacheron Constantin, Piaget, Baume & Mercier — 20% of sales), and Fashion & Accessories (Montblanc, Chloé, Dunhill — 13% of sales). Founded 1988 by Johann Rupert (South Africa) as a spin-off from Rembrandt Group tobacco and mining interests.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.